Somatic mutations or loss of heterozygosity of gene coding Tumor Protein p53 (TP53) result in aberrant P53 expression and are linked to an aggressive phenotype, with a higher tumor stage and poorer survival rate [8]. The gene discussed is TP53; the disease is neoplasm.